Stay updated on Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial page.

Latest updates to the Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial page
- Check4 days agoChange DetectedThe Study Record Versions now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link as well as Revision: v3.3.2 were removed from the footer.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe history now shows a new revision entry (v3.3.2) and the removal of the previous revision entry (v3.3.1) as part of page version updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedThe history now includes a new revision entry v3.3.1 and the v3.2.0 entry was removed; no other study content appears to be updated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe government funding/operating-status notice on the page has been removed, and the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check54 days agoChange DetectedNew version entry added to the Study History with an updated Study Status and related details. This indicates the latest recruitment status for the trial.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a government funding notice and operating status details plus a version upgrade to v3.2.0; removed the v3.1.0 tag.SummaryDifference12%

Stay in the know with updates to Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial page.